Search Results 1271-1280 of 27545 for female

1. Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

   Male or female subjects aged ≥65 years. · Voluntary written informed consent before performance of any study related procedure not part of normal medical care.

2. Mesenteric lymphadenitis - Symptoms and causes - Mayo Clinic

   This condition involves swollen lymph nodes in the membrane that connects the bowel to the abdominal wall. It usually affects children and teens.

3. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   ... female subject), during the study, and until 90 days (male) or 30 days (female) after the last dose of IMP. Able to walk at least 150 meters during the 6MWT ...

4. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

   ... female subjects and for 90 days after the last dose of study treatment for male subjects. Highly effective methods of contraception include the following ...

5. Prolactinoma - Diagnosis & treatment - Mayo Clinic

   Learn how this pituitary gland tumor changes some hormone levels and can lead to health concerns such as infertility, low libido and vision problems.

6. Citalopram (oral route) - Side effects & dosage - Mayo Clinic

   breast tenderness or enlargement or unusual secretion of milk (in females); chills; delayed or inability to have an orgasm; diarrhea; difficulty with ...

7. Exercise intensity: How to measure it - Mayo Clinic

   How hard should you be exercising? For most healthy adults, the Department of Health and Human Services recommends these exercise guidelines: Aerobic activity.

8. A Clinical Study To Test How Effective And Safe GLPG1690 Is For Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

   ... female subject), during the study, and until 90 days (male) or 30 days (female) after the last dose of IMP. Able to walk at least 150 meters during the 6MWT ...

9. Mayo Clinic Minute: Why more preventive screenings are needed in the Hispanic community

   ... females, are all available tools," he says. Talk with your doctor to ... female hands with pen writing on notebook Prepare a list of questions for ...

10. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ ...